SciGen Ltd (SIE.AX) Awarded Good Manufacturing Practices (GMP) Certification for Sci B Vac
1/23/2008 12:50:44 PM
Sydney, Jan 23, 2008 (ABN Newswire) - SciGen Limited (ASX: SIE) announces that it has been awarded the GMP certification of its manufacturing facility in Rehovot, Israel where its third generation hepatitis B vaccine Sci B Vac is manufactured. This comes after having successfully implemented and complied with all the requirements as specified by the World Health Organisation (WHO) and the Ministry of Health of Israel.
comments powered by